BIOA

Latest SEC Filings & News for BIOA

1 most recent filing and news item mentioning BIOA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/BIOA/news?limit=20"

Pull BIOA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Positive

BioAge Reports Q2 2026 Results, Doses First Participant in BGE-102 Phase 2 Trial

BioAge Labs dosed the first participant in its Phase 2 trial of BGE-102 and plans to initiate a proof-of-concept trial for diabetic macular edema, signaling progress in its NLRP3 inhibition strategy.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.